Halmont Properties (HMT) Stock Price, News & Analysis

Company Overview

Halmont Properties Corporation invests in real assets in Canada. The company invests in low-rise office, retail, residential, and industrial properties. It also invests in freehold timberlands and related manufacturing facilities. In addition, it provides financing and property advisory services to client companies. The company was formerly known as H.A.L. Concepts, Ltd. and changed its name to Halmont Properties Corporation in February 2007. Halmont Properties Corporation was incorporated in 2000 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$0.95 to C$0.95
• 50-Day Range: C$0.95 to C$1.19
• 52-Week Range: C$0.70 to C$1.19
• Volume: 100 shs
• Average Volume: 1,135 shs
• Market Capitalization: C$117.74 million
• P/E Ratio: 6.44
• Dividend Yield: 1.16%
• Price Target: N/A
• Consensus Rating: N/A

HMT Stock Analysis - Frequently Asked Questions

How have HMT shares performed this year?

Halmont Properties' stock was trading at C$0.85 at the beginning of 2025. Since then, HMT stock has increased by 11.8% and is now trading at C$0.95.
View the best growth stocks for 2025 here.

How do I buy shares of Halmont Properties?

Shares of HMT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Halmont Properties own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Halmont Properties investors own include Chatham Lodging Trust (CLDT), Bristol Myers Squibb (BMY), Brookfield Infrastructure Partners (BIP.UN), Badger Daylighting (BAD), Alibaba Group (BABA), Accelerate Diagnostics (AXDX) and Avadel Pharmaceuticals (AVDL).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Real Estate
• Industry: Real Estate - Development
• Sub-Industry: Trading
• Current Symbol: CVE:HMT
• CIK: N/A
• Web: N/A
• Phone: +1-416-9565140
• Fax: N/A
• Employees: 160
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C$0.15
• Trailing P/E Ratio: 6.44
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$18.28 million
• Net Margins: 121.75%
• Pretax Margin: N/A
• Return on Equity: 13.44%
• Return on Assets: 3.56%

Debt

• Debt-to-Equity Ratio: 74.54
• Current Ratio: 12.68
• Quick Ratio: 0.77

Sales & Book Value

• Annual Sales: C$15.02 million
• Price / Sales: 7.84
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 850.00
• Book Value: C$1.32 per share
• Price / Book: 0.72

Miscellaneous

• Outstanding Shares: 123,940,003
• Free Float: N/A
• Market Cap: C$117.74 million
• Optionable: Not Optionable
• Beta: -0.53